Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Purchased by Hotchkis & Wiley Capital Management LLC

Hotchkis & Wiley Capital Management LLC lifted its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 128.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 89,010 shares of the medical instruments supplier's stock after buying an additional 50,030 shares during the period. Hotchkis & Wiley Capital Management LLC owned approximately 2.63% of Utah Medical Products worth $5,956,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Copeland Capital Management LLC acquired a new position in shares of Utah Medical Products in the third quarter valued at approximately $53,000. BNP Paribas Financial Markets grew its holdings in shares of Utah Medical Products by 102.7% during the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier's stock worth $75,000 after purchasing an additional 566 shares during the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in shares of Utah Medical Products in the 2nd quarter valued at about $83,000. Victory Capital Management Inc. lifted its holdings in shares of Utah Medical Products by 124.4% in the 2nd quarter. Victory Capital Management Inc. now owns 2,673 shares of the medical instruments supplier's stock valued at $179,000 after purchasing an additional 1,482 shares during the last quarter. Finally, GSA Capital Partners LLP purchased a new position in Utah Medical Products during the 3rd quarter worth approximately $231,000. Hedge funds and other institutional investors own 69.60% of the company's stock.

Utah Medical Products Stock Performance

NASDAQ UTMD traded up $0.10 during trading on Friday, reaching $63.84. The company's stock had a trading volume of 17,587 shares, compared to its average volume of 21,874. The business's fifty day moving average price is $65.52 and its 200-day moving average price is $66.97. Utah Medical Products, Inc. has a twelve month low of $63.02 and a twelve month high of $87.00. The firm has a market cap of $216.42 million, a price-to-earnings ratio of 14.78 and a beta of 0.08.

Utah Medical Products Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Shareholders of record on Monday, December 16th will be given a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a yield of 1.91%. This is a boost from Utah Medical Products's previous quarterly dividend of $0.30. The ex-dividend date is Monday, December 16th. Utah Medical Products's dividend payout ratio (DPR) is presently 28.10%.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Utah Medical Products from a "strong-buy" rating to a "buy" rating in a report on Thursday, November 7th.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.